Massive global study aims to unlock secrets of severe pneumonia care
NCT ID NCT07301099
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study will track over 2,500 adults hospitalized with severe community-acquired pneumonia across dozens of countries. Researchers will collect data from medical records to see how closely hospitals follow international treatment guidelines and what factors lead to better or worse outcomes. No new drugs or procedures are being tested — the goal is simply to learn from real-world care to improve future treatment and survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors worldwide improve how they diagnose and treat severe pneumonia, potentially saving more lives.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test any new drug or therapy, so it cannot directly cure or prevent pneumonia.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clínica Universidad de La Sabana
Chía, Colombia
More trials for these conditions
Other studies related to the condition(s) this trial covers.